Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10537567 Kinase inhibitors for treatment of disease

Patent 10537567 was granted and assigned to BioAxone Biosciences on January, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Bioaxone Biosciences, Inc.

0

Current Assignee

BioAxone Biosciences

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Matthew D. Abbinanti0

Joerg Ruschel0

Kenneth M. Rosen0

Lisa McKerracher0

Date of Patent

January 21, 2020

0

Patent Application Number

160324420

Date Filed

July 11, 2018

0

Patent Citations

US Patent 10106525 Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

US Patent 10149856 Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors

Patent Citations Received

US Patent 11701366 Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors

0

Patent Primary Examiner

D Margaret M Seaman

0

Patent abstract

Disclosed are therapeutic compositions including BA-1076 and/or BA-2057, methods of their use in the treatment of ophthalmological disorders. The therapeutic compositions may further include an IOP-lowering prostaglandin. The methods may further include administration of an IOP-lowering prostaglandin.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10537567 Kinase inhibitors for treatment of disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool